6.
Bhattacharya A, Vo D, Jops C, Kim M, Wen C, Hervoso J
. Isoform-level transcriptome-wide association uncovers genetic risk mechanisms for neuropsychiatric disorders in the human brain. Nat Genet. 2023; 55(12):2117-2128.
PMC: 10703692.
DOI: 10.1038/s41588-023-01560-2.
View
7.
Alexopoulou Z, Lang J, Perrett R, Elschami M, Hurry M, Kim H
. Deubiquitinase Usp8 regulates α-synuclein clearance and modifies its toxicity in Lewy body disease. Proc Natl Acad Sci U S A. 2016; 113(32):E4688-97.
PMC: 4987833.
DOI: 10.1073/pnas.1523597113.
View
8.
Brandes N, Linial N, Linial M
. PWAS: proteome-wide association study-linking genes and phenotypes by functional variation in proteins. Genome Biol. 2020; 21(1):173.
PMC: 7386203.
DOI: 10.1186/s13059-020-02089-x.
View
9.
Gusev A, Ko A, Shi H, Bhatia G, Chung W, Penninx B
. Integrative approaches for large-scale transcriptome-wide association studies. Nat Genet. 2016; 48(3):245-52.
PMC: 4767558.
DOI: 10.1038/ng.3506.
View
10.
Cheng F, Zhao J, Wang Y, Lu W, Liu Z, Zhou Y
. Comprehensive characterization of protein-protein interactions perturbed by disease mutations. Nat Genet. 2021; 53(3):342-353.
PMC: 8237108.
DOI: 10.1038/s41588-020-00774-y.
View
11.
Hu T, Parrish R, Dai Q, Buchman A, Tasaki S, Bennett D
. Omnibus proteome-wide association study identifies 43 risk genes for Alzheimer disease dementia. Am J Hum Genet. 2024; 111(9):1848-1863.
PMC: 11393696.
DOI: 10.1016/j.ajhg.2024.07.001.
View
12.
Wu P, Tsai P, Chen G, Chou H, Huang Y, Chen Y
. DAPK activates MARK1/2 to regulate microtubule assembly, neuronal differentiation, and tau toxicity. Cell Death Differ. 2011; 18(9):1507-20.
PMC: 3178434.
DOI: 10.1038/cdd.2011.2.
View
13.
Zhong J, Jermusyk A, Wu L, Hoskins J, Collins I, Mocci E
. A Transcriptome-Wide Association Study Identifies Novel Candidate Susceptibility Genes for Pancreatic Cancer. J Natl Cancer Inst. 2020; 112(10):1003-1012.
PMC: 7566474.
DOI: 10.1093/jnci/djz246.
View
14.
Murrell J, Farlow M, Ghetti B, Benson M
. A mutation in the amyloid precursor protein associated with hereditary Alzheimer's disease. Science. 1991; 254(5028):97-9.
DOI: 10.1126/science.1925564.
View
15.
Cordell H
. Detecting gene-gene interactions that underlie human diseases. Nat Rev Genet. 2009; 10(6):392-404.
PMC: 2872761.
DOI: 10.1038/nrg2579.
View
16.
Chautard E, Thierry-Mieg N, Ricard-Blum S
. Interaction networks: from protein functions to drug discovery. A review. Pathol Biol (Paris). 2008; 57(4):324-33.
DOI: 10.1016/j.patbio.2008.10.004.
View
17.
Lu H, Zhou Q, He J, Jiang Z, Peng C, Tong R
. Recent advances in the development of protein-protein interactions modulators: mechanisms and clinical trials. Signal Transduct Target Ther. 2020; 5(1):213.
PMC: 7511340.
DOI: 10.1038/s41392-020-00315-3.
View
18.
Van Steen K
. Travelling the world of gene-gene interactions. Brief Bioinform. 2011; 13(1):1-19.
DOI: 10.1093/bib/bbr012.
View
19.
Meuleman W, Muratov A, Rynes E, Halow J, Lee K, Bates D
. Index and biological spectrum of human DNase I hypersensitive sites. Nature. 2020; 584(7820):244-251.
PMC: 7422677.
DOI: 10.1038/s41586-020-2559-3.
View
20.
Lao K, Zhang R, Dai Y, Luan J, Guo N, Xu X
. Identification of novel Aβ-LilrB2 inhibitors as potential therapeutic agents for Alzheimer's disease. Mol Cell Neurosci. 2021; 114:103630.
DOI: 10.1016/j.mcn.2021.103630.
View